Smart Technology Facilitated Venous Thromboembolism Prophylaxis Based on Bundled Evidence-based Prevention Strategies

Launched by NAVY GENERAL HOSPITAL, BEIJING · Apr 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how to improve the prevention of venous thromboembolism (VTE), which is a serious condition that can cause blood clots in the veins. VTE is a significant cause of health problems and deaths, especially in hospitals. The trial will look at how well a smart technology system called DeVTEcare, which helps assess patients' risk for VTE and manage their care, works when combined with proven prevention strategies. The goal is to ensure that more patients receive the right preventive measures during their hospital stay.

To participate in this study, individuals must be at least 18 years old and have been hospitalized for a longer period. Those with certain conditions, like existing blood clot issues or who are already on blood-thinning medications, won't be included. If you join the trial, you can expect to be monitored for how well the new prevention strategies work in reducing the risk of VTE while you are in the hospital. This research is important because it aims to improve patient safety and care during hospital stays.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Discharged patients who were ≥18 years of age at admission were included in the observation cohort. If a patient had multiple hospitalizations, information on only the longest hospitalization was included in the study.
• Exclusion Criteria:
• • Lack of diagnostic information；
• • Length of hospitalization ≤ 24 hours；
• • Patients on anticoagulation therapy at the time of admission: e.g., those with established VTE, atrial fibrillation, acute myocardial infarction, ischemic stroke, those on continuous renal replacement therapy, extracorporeal membrane pulmonary oxygenation, hemodialysis, and mechanical valve implantation status.